[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Anna Arthur, PhD\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":56},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":10,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":25,"conditions":26,"keywords":28,"overallStatus":44,"whyStopped":4,"lastUpdateSubmitDate":45,"lastUpdatePostDateStruct":46,"startDateStruct":49,"completionDateStruct":51,"leadSponsor":53,"locationsCount":4},"100606824",false,"NCT07180576","The FORCE Trial Pilot: Fish Oil-enriched Nutrition for Radiotherapy in Cancer of the hEad and Neck","The FORCE Trial Pilot","FORCE","Inclusion Criteria:\n\n* Newly diagnosed with Stage I - IV oral cavity, hypopharyngeal, oropharyngeal, or laryngeal cancer\n* Age 18+\n* Planned for definitive radiotherapy with or without surgery and chemotherapy\n\nExclusion Criteria:\n\n* Metastatic disease\n* Prior head\u002Fneck RT\n* Presence of malnutrition at diagnosis per ASPEN criteria\n* Prior cancer within 3 years (except non-melanoma skin cancer and cervical carcinoma in situ)\n* Inability to consent\n* Severe psychiatric illness\n* Medical conditions impairing participation\u002Fadherence\n* Non-adults, pregnant women, prisoners, and other legally protected vulnerable groups\n* Dairy, soy, and\u002For fish allergy\n* Non-English speaking\n* Documented history of atrial fibrillation or other significant arrhythmias\n* Receiving therapeutic anticoagulation (e.g., warfarin, direct oral anticoagulants) and\u002For clotting disorders (e.g., hemophilia, thrombocytopenia)","ALL","18 Years",{"count":19,"type":20},15,"ESTIMATED","INTERVENTIONAL",[23,24],"PHASE1","PHASE2","en-label, proof-of-concept study designed to evaluate the feasibility, safety, and acceptability of a prophylactic fish oil-enriched nutritional supplement (Fresubin Supportan) in patients with head and neck cancer (HNC) undergoing curative-intent chemoradiotherapy (CRT) at the University of Kansas Medical Center. The study involves daily supplementation starting two weeks prior to CRT and continuing throughout CRT, alongside weekly nutrition counseling.",[27],"Head &Amp;Amp; Neck Squamous Cell Carcinoma",[29,30,31,32,33,34,35,36,37,38,39,40,41,42,43],"nutrition","head and neck cancer","nutrition supplement","nutrition trial","fish oil","cancer patient","sarcopenia","nutrition impact symptoms","body composition","cancer","oncology","fatty acid","cancer survivor","oral nutrition supplement","supportive care","NOT_YET_RECRUITING","2025-09-11",{"date":47,"type":48},"2025-09-18","ACTUAL",{"date":50,"type":20},"2026-01-01",{"date":52,"type":20},"2027-12-31",{"name":54,"class":55},"Anna Arthur, PhD","OTHER",""]